Diarmuid Coughlan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

PharmacoEconomics

Emergency medicine journal : EMJ

BMJ open sport & exercise medicine

MDM policy & practice

Newcastle University

National University of Ireland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Newcastle University Sep 18 2017

United Kingdom

Research Associate :: Institute of Health & Society

National Cancer Institute Jun 10 2015 - Sep 15 2017

United States

Cancer Prevention Fellow :: Surveillance Research Program

Newcastle University May 20 2014 - May 31 2015

United Kingdom

Teaching Fellow :: Institute of Health & Society

Education History

National University of Ireland Jul 04 2010 - May 20 2014

Ireland

PHD :: Economics

University of York Sep 01 2008 - Sep 30 2009

United Kingdom

MSC :: Economics

University College Cork Sep 01 2007 - Sep 01 2008

Ireland

MSC :: School of Pharmacy

Publications

Giovany Orozco-Leal, Nigel Armstrong, Ashleigh Kernohan, Charlotte Ahmadu, Diarmuid Coughlan, Kevin T McDermott, Steven Duffy, Susan O'Meara, Tomos Robinson, Luke Vale, Jos Kleijnen
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics (2023)
Diarmuid Coughlan, Oluwatomi Arisa, Katie H Thomson, Ge Yu, Fiona Pearson, Ashleigh Kernohan, Sonia Garcia Gonzalez-Moral, Sheila A Wallace, Stephen Rice
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective. PharmacoEconomics (2023)
Giovany Orozco-Leal, Nigel Armstrong, Ashleigh Kernohan, Charlotte Ahmadu, Diarmuid Coughlan, Kevin T McDermott, Steven Duffy, Susan O'Meara, Tomos Robinson, Luke Vale, Jos Kleijnen
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics (2023)
Vasileios Kontogiannis, Diarmuid Coughlan, Mehdi Javanbakht, Tafadzwa Patience Kunonga, Fiona Beyer, Catherine Richmond, Andy Bryant, Dalvir Bajwa, Robert A Ellis, Luke Vale
Optimal Surveillance Strategies for Early-Stage Cutaneous Melanoma Post Primary Tumor Excision: An Economic Evaluation. MDM policy & practice 7 (1) (2022)
Diarmuid Coughlan, Pedro F Saint-Maurice, Susan A Carlson, Janet Fulton, Charles E Matthews
Leisure time physical activity throughout adulthood is associated with lower medicare costs: evidence from the linked NIH-AARP diet and health study cohort. BMJ open sport & exercise medicine 7 (1) (2021)
Luke Vale, Tafadzwa Patience Kunonga, Diarmuid Coughlan, Vasileios Kontogiannis, Margaret Astin, Fiona R Beyer, Catherine Richmond, Dor Wilson, Dalvir Bajwa, Mehdi Javanbakht, Andrew Bryant, Wanwuri Akor, Dawn Craig, Penny E Lovat, Marie Labus, Batoul Nasr, Timothy Cunliffe, Helena Hinde, Mohamed Shawgi, Daniel Saleh, Pam Royle, Paul Steward, Rachel Lucas, Robert Ellis
Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model. Health technology assessment (Winchester, England) 25 (64) (2021)
Diarmuid Coughlan, Peter McMeekin, Darren Flynn, Gary A Ford, Hannah Lumley, David Burgess, Joyce Balami, Andrew Mawson, Dawn Craig, Stephen Rice, Phil White
Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerations. Emergency medicine journal : EMJ 38 (1) (2020)

Diarmuid Coughlan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Diarmuid Coughlan